Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106.
暂无分享,去创建一个
Yoshiro Okubo | Hiroshi Ito | Hidehiko Takahashi | Akihiro Takano | Ryohei Matsumoto | Ryosuke Arakawa | Tetsuya Suhara | Hidehiko Takahashi | T. Suhara | Y. Okubo | Hiroshi Ito | A. Takano | R. Arakawa | Ryohei Matsumoto | Amane Tateno | Amane Tateno
[1] T. Suslow,et al. Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[2] H. Nawa,et al. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines , 2006, Neuroscience Research.
[3] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[4] F. Yasuno,et al. Increased Binding of Peripheral Benzodiazepine Receptor in Alzheimer's Disease Measured by Positron Emission Tomography with [11C]DAA1106 , 2008, Biological Psychiatry.
[5] X. Zhang,et al. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. , 2004, The Journal of clinical psychiatry.
[6] Y. Sudo,et al. Ten year progressive ventricular enlargement in schizophrenia: An MRI morphometrical study , 2001, Psychiatry and clinical neurosciences.
[7] R. Pioli,et al. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 , 1998, Schizophrenia Research.
[8] S. Eiduson. Biochemistry and behavior , 1965 .
[9] Makoto Sawada,et al. Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies , 2008, The Journal of Neuroscience.
[10] Ryuji Nakao,et al. Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] J. Feldon,et al. Peripheral benzodiazepine receptors reflect trait (early handling) but not state (avoidance learning) , 2002, Pharmacology Biochemistry and Behavior.
[12] Norbert Müller,et al. COX-2 inhibition in schizophrenia and major depression. , 2008, Current pharmaceutical design.
[13] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[14] D. B. Stone. Biochemistry and Behavior. , 1966 .
[15] K O Lim,et al. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. , 2001, Archives of general psychiatry.
[16] Abraham Weizman,et al. Acute and Repeated Swim Stress Effects on Peripheral Benzodiazepine Receptors in the Rat Hippocampus, Adrenal, and Kidney , 2001, Neuropsychopharmacology.
[17] Takahiro A. Kato,et al. Risperidone significantly inhibits interferon-γ-induced microglial activation in vitro , 2007, Schizophrenia Research.
[18] Emmanuel Stip,et al. Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review , 2008, Biological Psychiatry.
[19] K. Suk,et al. The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production , 2008, Journal of neurochemistry.
[20] K. Labuzek,et al. Flupentixol and trifluperidol reduce interleukin-1 beta and interleukin-2 release by rat mixed glial and microglial cell cultures. , 2004, Polish journal of pharmacology.
[21] S Ogawa,et al. Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106. , 1999, Life sciences.
[22] S. Hume,et al. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. , 1994, Nuclear medicine and biology.
[23] René S. Kahn,et al. Microglia activation in schizophrenia , 2010, NeuroImage.
[24] J. Ryu,et al. Inhibition of lipopolysaccharide‐induced cyclooxygenase‐2, tumor necrosis factor‐α and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195 , 2002, Journal of neurochemistry.
[25] B. Gabryel,et al. Chlorpromazine and loxapine reduce interleukin-1β and interleukin-2 release by rat mixed glial and microglial cell cultures , 2004, European Neuropsychopharmacology.
[26] J. Lieberman,et al. Longitudinal study of brain morphology in first episode schizophrenia , 2001, Biological Psychiatry.
[27] J. Bart,et al. P-glycoprotein activity and biological response. , 2005, Toxicology and applied pharmacology.
[28] G. Deuschl,et al. Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro , 2003, Neurobiology of Disease.
[29] T. Pollmächer,et al. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever , 2009, Psychoneuroendocrinology.
[30] K. Labuzek,et al. Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-α and nitric oxide by rat microglial cells , 2003, Neurochemistry International.
[31] J. Jakubikova,et al. PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro. , 2002, Neoplasma.
[32] Tetsuya Suhara,et al. [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. , 2003, Nuclear medicine and biology.
[33] Rudi A. Dierckx,et al. Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study , 2009, Journal of Nuclear Medicine.
[34] S. Chaki,et al. Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors. , 1999, European journal of pharmacology.
[35] Yuji Nagai,et al. Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.
[36] S. Akhondzadeh,et al. Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial , 2007, Schizophrenia Research.
[37] R. McCarley,et al. A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.
[38] B. Bogerts,et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. , 2008, Journal of psychiatric research.
[39] A. L. Goldin,et al. Neurobiology of Disease , 2014 .